亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳石金谷科技有限公司  

化學合成原料藥、醫藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家供應CAS號:550-99-2禁發 鹽酸萘甲唑啉原料
廠家供應CAS號:550-99-2禁發 鹽酸萘甲唑啉原料
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 南箭
型號 550-99-2
規格 醫藥級
過期 長期有效
更新 2013-08-13 11:01
 
詳細信息
廠家供應CAS號:550-99-2禁發 鹽酸萘甲唑啉原料
禁發 鹽酸萘甲唑啉
產品名稱:禁發 鹽酸萘甲唑啉
英文名:Naphazoline Hydrochloride
別名:禁發 鹽酸萘唑啉、鼻眼凈、滴鼻凈、禁發 鹽酸納發唑啉。
CAS號:550-99-2
包裝:25kg/桶
含量:>99.0%
質量標準:BP;USP
外觀:白色或接近白色結晶性粉末 
作用與用途: 本品為α-受體激動劑,具有收縮鼻粘膜血管作用,減少血管的滲出物,減輕鼻粘膜腫脹充血。臨床用于治傷風過敏性鼻炎、炎癥性鼻充血、急慢性鼻炎。

Naphazoline Hydrochloride BP;USP 99.0%
Product name: Naphazoline Hydrochloride
CAS Registry Number: 550-99-2
Assays: 99.0%
Packaging: 25kg/drum
Qualitity Standard: BP;USP
Appearance: White or nearly white crystalline powder
©2025 深圳石金谷科技有限公司 版權所有   技術支持:化工網   訪問量:28656  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |